AG-13958

TargetMol
Product Code: TAR-T7493
Supplier: TargetMol
CodeSizePrice
TAR-T7493-1mg1mg£169.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7493-2mg2mg£215.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7493-5mg5mg£351.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7493-1mL1 mL * 10 mM (in DMSO)£352.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7493-10mg10mg£490.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7493-25mg25mg£751.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7493-50mg50mg£1,010.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7493-100mg100mg£1,340.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
AG-13958 (AG-013958), a potent VEGFR tyrosine kinase inhibitor, for the treatment of age-related macular degeneration.
CAS:
319460-94-1
Formula:
C26H22FN7O
Molecular Weight:
467.508
Pathway:
Angiogenesis; Tyrosine Kinase/Adaptors
Purity:
0.9984
SMILES:
Cc1cc(C(=O)Nc2cc(Nc3ccc4c(C=Cc5ccccn5)n[nH]c4c3)ccc2F)n(C)n1
Target:
VEGFR

References

Chappelow A V , Kaiser P K . Neovascular age-related macular degeneration: potential therapies[J]. Drugs, 2008, 68(8):1029-1036. Barakat M R , Kaiser P . VEGF inhibitors for the treatment of neovascular age-related macular degeneration[J]. Expert Opinion on Investigational Drugs, 2009, 18(5):637-646.